封面
市场调查报告书
商品编码
1589003

智慧胰岛素笔和帮浦的全球市场

Smart Insulin Pens and Pumps

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 89 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年,全球智慧胰岛素笔和帮浦市场将达到 92 亿美元

智慧胰岛素笔和帮浦的全球市场预计 2023 年为 52 亿美元,预计到 2030 年将达到 92 亿美元,2023-2030 年分析期间复合年增长率为 8.6%。智慧胰岛素帮浦是本报告分析的细分市场之一,预计复合年增长率为 8.1%,到分析期结束时将达到 79 亿美元。分析期间,智慧胰岛素笔产业的复合年增长率预计为 12.7%。

美国市场预计14亿美元,中国预计复合年增长率8.2%

预计 2023 年美国智慧胰岛素笔和帮浦市场规模将达 14 亿美元。中国作为世界第二大经济体,预计到 2030 年市场规模将达到 14 亿美元,2023-2030 年分析期间复合年增长率为 8.2%。其他值得注意的区域市场包括日本和加拿大,在分析期间预计复合年增长率分别为 8.1% 和 7.1%。在欧洲,德国的复合年增长率预计约为 7.0%。

全球智慧胰岛素笔和帮浦市场—主要趋势和驱动因素总结

智慧胰岛素笔和帮浦如何增强糖尿病管理?

智慧胰岛素笔和帮浦是先进的医疗设备,旨在透过提供准确、即时的资料和个人化的胰岛素剂量来改善糖尿病管理。智慧笔提供测量量的胰岛素,智慧帮浦根据使用者的血糖浓度提供连续的皮下胰岛素输注。这些设备提供蓝牙连接、剂量追踪和行动应用程式整合等功能,使用户能够准确监控和调整胰岛素的使用情况。智慧胰岛素笔和帮浦透过支援个人化治疗和降低併发症风险,正在改变第 1 型和第 2 型糖尿病患者的糖尿病照护。

智慧胰岛素笔和帮浦市场的关键细分市场有哪些?

主要产品类型包括智慧胰岛素笔、智慧胰岛素帮浦和连网型胰岛素帽,其中智慧胰岛素帮浦因其连续血糖监测(CGM)支援和自动化胰岛素给药能力而占据最大的市场占有率。主要应用是第1型糖尿病和第2型糖尿病,其中第1型糖尿病占重要部分,因为第1型糖尿病患者需要持续的胰岛素管理。最终用户包括医院、诊所和居家医疗,由于糖尿病患者越来越多地采用自我管理工具,居家医疗引领市场。

智慧胰岛素设备如何融入糖尿病照护?

智慧胰岛素笔具有剂量记忆、剂量建议和错过剂量警报等功能,可帮助使用者有效管理用餐时间并修正胰岛素。智慧型帮浦通常与连续血糖监测 (CGM) 系统集成,根据血糖读数自动调整胰岛素输送,以支援稳定的血糖值。在医院和诊所,这些设备用于改善胰岛素治疗效果、减少错误,并向医疗保健专业人员提供即时资料以进行病患监测。此外,家庭护理患者可以使用与智慧笔和帮浦配合使用的行动应用程式来追踪胰岛素使用情况、查看血糖趋势并接受个人化治疗调整,以支持更好的自我护理和依从性。

推动智慧胰岛素笔和帮浦市场成长的因素有哪些?

智慧胰岛素笔和帮浦市场的成长受到多种因素的推动,包括糖尿病盛行率的增加以及对更有效的胰岛素管理解决方案的需求不断增长。连接性、剂量准确性和 CGM 整合等设备技术的进步正在提高使用者便利性和治疗效果。人们对糖尿病治疗中的个人化医疗和自我管理的日益关注正在加速智慧胰岛素设备的采用。随着患者寻求先进的解决方案来提高生活质量,政府促进数位健康和​​慢性病管理的措施进一步推动了需求。此外,医疗保健提供者对减少再入院和改善患者治疗效果的关注也促进了智慧胰岛素笔和帮浦的普及。

受访企业范例(33家知名企业)

  • Cellenovo
  • Companion Medical Inc.
  • Emperra Gmbh E-Health Technologies
  • F Hoffmann-La Roche
  • Insulet Corporation
  • Jiangasu Delfu Medical Device Co Ltd
  • Medical Inc.
  • Medtronic Inc.
  • Novo Nordisk
  • Sooil Development
  • Tandem Diabetes Care
  • Valeritas Inc.
  • Ypsomed

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP22791

Global Smart Insulin Pens and Pumps Market to Reach US$9.2 Billion by 2030

The global market for Smart Insulin Pens and Pumps estimated at US$5.2 Billion in the year 2023, is expected to reach US$9.2 Billion by 2030, growing at a CAGR of 8.6% over the analysis period 2023-2030. Smart Insulin Pumps, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$7.9 Billion by the end of the analysis period. Growth in the Smart Insulin Pens segment is estimated at 12.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 8.2% CAGR

The Smart Insulin Pens and Pumps market in the U.S. is estimated at US$1.4 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 8.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.1% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.0% CAGR.

Global Smart Insulin Pens and Pumps Market - Key Trends and Drivers Summarized

How Are Smart Insulin Pens and Pumps Enhancing Diabetes Management?

Smart insulin pens and pumps are advanced medical devices designed to improve diabetes management by providing accurate, real-time data and personalized insulin delivery. Smart pens deliver insulin in measured doses, while smart pumps provide continuous subcutaneous insulin infusion based on the user's glucose levels. These devices offer features like Bluetooth connectivity, dose tracking, and integration with mobile apps, enabling users to monitor and adjust insulin usage with precision. By supporting personalized therapy and reducing the risk of complications, smart insulin pens and pumps are transforming diabetes care for both Type 1 and Type 2 diabetics.

What Are the Key Segments in the Smart Insulin Pens and Pumps Market?

Key product types include smart insulin pens, smart insulin pumps, and connected insulin caps, with smart insulin pumps holding the largest market share due to their continuous glucose monitoring (CGM) compatibility and ability to automate insulin delivery. Major applications cover Type 1 and Type 2 diabetes, with Type 1 diabetes representing a significant segment as these patients require consistent insulin management. End-users include hospitals, clinics, and home care, with home care leading the market due to the increasing adoption of self-management tools by diabetic patients.

How Are Smart Insulin Devices Integrated Across Diabetes Care?

Smart insulin pens are equipped with dose memory, dose recommendations, and missed dose alerts, helping users manage mealtime and correction insulin effectively. Smart pumps, often integrated with continuous glucose monitoring (CGM) systems, automatically adjust insulin delivery based on glucose readings, supporting stable blood sugar levels. In hospitals and clinics, these devices are used to improve insulin therapy outcomes, reduce errors, and provide real-time data to healthcare professionals for patient monitoring. Additionally, home care patients use mobile apps linked to smart pens and pumps to track insulin usage, review glucose trends, and receive personalized therapy adjustments, supporting better self-care and adherence.

What Factors Are Driving the Growth in the Smart Insulin Pens and Pumps Market?

The growth in the Smart Insulin Pens and Pumps market is driven by several factors, including increasing diabetes prevalence, which has heightened the need for more effective insulin management solutions. Advancements in device technology, such as improved connectivity, dose accuracy, and CGM integration, have enhanced user convenience and therapy outcomes. The rising focus on personalized medicine and self-management in diabetes care has accelerated the adoption of smart insulin devices. Government initiatives promoting digital health and chronic disease management have further fueled demand, as patients seek advanced solutions to improve quality of life. Additionally, healthcare providers’ focus on reducing hospital readmissions and improving patient outcomes has contributed to the widespread adoption of smart insulin pens and pumps.

Select Competitors (Total 33 Featured) -

  • Cellenovo
  • Companion Medical Inc.
  • Emperra Gmbh E-Health Technologies
  • F Hoffmann-La Roche
  • Insulet Corporation
  • Jiangasu Delfu Medical Device Co Ltd
  • Medical Inc.
  • Medtronic Inc.
  • Novo Nordisk
  • Sooil Development
  • Tandem Diabetes Care
  • Valeritas Inc.
  • Ypsomed

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Smart Insulin Pens and Pumps - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Diabetes Spurs Demand for Smart Insulin Pens and Pumps
    • Technological Advancements in Real-Time Glucose Monitoring and Automated Insulin Delivery Drive Adoption
    • Growing Focus on Personalized Diabetes Management Expands Addressable Market for Smart Insulin Devices
    • Expansion of Smart Insulin Solutions in Home Healthcare and Remote Patient Monitoring Fuels Market Growth
    • Increasing Demand for Accurate Dosing, Safety Alerts, and Predictive Analytics Drives Adoption
    • Integration with Mobile Apps, AI-Powered Coaching, and Data Analytics Strengthens Business Case
    • Rising Focus on Patient Adherence, Dosage Tracking, and Data-Driven Insights Accelerates Demand
    • Technological Innovations in Needle-Free Insulin Delivery and Wearable Infusion Pumps Propel Market Growth
    • Growing Use of Smart Insulin Devices in Pediatrics, Geriatrics, and Special Populations Drives Adoption
    • Focus on Achieving Seamless Integration with Telehealth Platforms Expands Addressable Market
    • Technological Advancements in Long-Lasting Battery, Compact Design, and Bluetooth Connectivity Propel Growth
    • Rising Demand for Cost-Effective, Reusable, and Disposable Smart Insulin Devices Generates Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World 7-Year Perspective for Smart Insulin Pens and Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 4: World 7-Year Perspective for Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Pens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World 7-Year Perspective for Pens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World 7-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 10: World 7-Year Perspective for Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World 7-Year Perspective for Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 13: World Smart Insulin Pens and Pumps Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Smart Insulin Pens and Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 16: USA Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 17: USA 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • CANADA
    • TABLE 18: Canada Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 19: Canada 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 20: Canada Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Canada 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • JAPAN
    • Smart Insulin Pens and Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 22: Japan Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 23: Japan 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 24: Japan Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 25: Japan 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • CHINA
    • Smart Insulin Pens and Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 26: China Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: China 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 28: China Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 29: China 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • EUROPE
    • Smart Insulin Pens and Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 30: Europe Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 31: Europe 7-Year Perspective for Smart Insulin Pens and Pumps by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 34: Europe Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 35: Europe 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • FRANCE
    • Smart Insulin Pens and Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 36: France Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 37: France 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 38: France Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: France 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • GERMANY
    • Smart Insulin Pens and Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 40: Germany Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 41: Germany 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 42: Germany Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 43: Germany 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • ITALY
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Italy 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 46: Italy Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Italy 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • UNITED KINGDOM
    • Smart Insulin Pens and Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 48: UK Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 49: UK 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 50: UK Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: UK 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 52: Rest of Europe Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 53: Rest of Europe 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 54: Rest of Europe Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 55: Rest of Europe 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Smart Insulin Pens and Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 58: Asia-Pacific Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 59: Asia-Pacific 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 60: Rest of World Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 61: Rest of World 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 62: Rest of World Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Rest of World 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030

IV. COMPETITION